Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CYB5R3 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | EFEMP2 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | KBTBD6 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | TM7SF3 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
mRNA | ATXN7L2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | NUP54 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | POLE3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | EXOSC3 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | SENP6 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |